The largest database of trusted experimental protocols

24 protocols using mopc 21

1

Phosphorylation Profiling of CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Following 7 days of aAPC stimulation and sirolimus treatment CD8+ T cells were re-stimulated with 10 μg/ml peptide (A02pp65) for 1 h and phosphorylation of extracellular regulated kinase 1/2 (pERK1/2), protein kinase B on Ser473 (pAktSer473), on Thr308 (pAktThr308), ribosomal protein 6 (pS6), STAT-5 (pSTAT-5) was evaluated by phospho-flow cytometry. Phosphorylation was determined by surface staining with anti-CD3-FITC (UCHT1) (BioLegend), anti-CD8-PerCP/Cy5.5 (RPA-T8) (BD), followed by fixation (Fix Buffer I, BD), permeabilization with Perm Buffer III (BD), and intracellular staining with anti-pS6-AlexaFlour647 (N7-548), anti-pERK1/2-AlexaFlour647 (20A), anti-pSTAT5-AlexaFlour647 (47/STAT5), or immunoglobulin (Ig)G1 AlexFlour647 isotype control (MOPC-21), anti-pAkt(T308)-PE (J1-223.371), anti-pAkt(S473)-PE (M89-61), or IgG1 PE isotype control (MOPC-21) (all BD).
+ Open protocol
+ Expand
2

Flow Cytometry of Neutrophil Apoptosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were stained with Alexa Fluor 647 conjugated CD11b (neutrophil differentiation marker, Biolegend, 301319, clone IV-M047) or the isotype control antibody (Biolegend, 400130, clone MOPC-21) and RUO AnnexinV (apoptosis marker, BD, 563973). Cells were stained in staining buffer (1%BSA 0.1% NaN3) and incubated on ice for 1 hour, washed three times with staining buffer and resuspended to suitable volume. Dendra 2 reporter expression levels were collected with the 488nM excitation filter and 530/30 PMT. Fluorescence intensity and collected using BD LSR Fortessa. Results were analyzed with Beckman Kaluza 2.1 software.
+ Open protocol
+ Expand
3

Quantification of PD-L1 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were stained with fluorescein isothiocyanate (FITC)-conjugated mAb specific for PD-L1 (MIH1) or the isotype control IgG (MOPC-21) and propidium iodide (PI) (BD Pharmingen). Cell acquisition and analysis were performed with FACSCalibur and CELLQuestPro software (Becton Dickinson). The relative mean fluorescence intensity (MFI) was calculated using the following equation: PD-L1 MFI/isotype control MFI in the PI-negative fraction.
+ Open protocol
+ Expand
4

NK Cell Activation and Conjugation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Untouched primary NK cells isolated from a healthy donor were split equally to stain half with 5 μM CellTrace™ CFSE and the other half with 5 μM CellTrace™ Violet for 15 min at 37°C according to the manufacturer’s instructions (Invitrogen). After labelling, cells were washed extensively. Then, 7.5×104 CFSE-stained NK cells and 7.5×104 Violet-stained NK cells were co-cultured at 37°C for 0 or 2 hours in a final volume of 150 μL with or without 10 ng/mL rhIL-12 + 50 ng/mL rhIL-18 + 1 ng/mL rhIL-15. Co-cultures with the combined cytokines were performed in the presence of 10 μg/mL of either isotype control antibody (MOPC-21; BD and 20116; R&D), anti-SEMA7A Ab (310829; R&D) or anti-CD29 antibody (P5D2; BioLegend). Isotype control antibodies were also added to the co-culture in medium alone. Reactions were stopped by adding 50 μL of ice-cold PBS. Conjugates were detected by flow cytometry as double positive events.
+ Open protocol
+ Expand
5

PBMC Activation and Phenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMC, 1x106 cells/ml of RPMI 1640 + 5% heat inactivated fetal bovine serum were incubated without PHA or BTP2 (control), with BTP2 (1000 nM), with PHA (2 μg/ml), or with PHA (2 μg/ml) + BTP2 (1000 nM) for 16 hours at 37°C in 95% air and 5% CO2 atmosphere. At the end of incubation, the cells were washed and labeled with FITC mouse IgG2a,k isotype control mAb (G155-178, BD Pharmingen) and PE Mouse IgG1, k isotype control mAb (MOPC-21, BD Pharmingen) or FITC mouse IgG2a, k anti-human CD3E mAb (HIT3a, BD Pharmingen) and PE mouse IgG1, k anti-human CD25 mAb (M-A251, BD Pharmingen). Each isotype mAb (10 μl) and each antibody marker (10 μl) for CD3E and CD25 was added to 100 μl of cell suspension in 5ml falcon tube. The sample tubes were vortexed and incubated in dark at 4 C for 30 min in refrigerator. After incubation, cells were washed by adding 3 ml of cold working wash buffer (PBS containing 1% FBS and 0.1% FBS and 0.1% wt/vol sodium azide). Cells were then resuspended in 400 μL of working fixative reagent (PBS + 0.1% sodium azide +1% fetal bovine serum + 37% formalin) and flow cytometry analysis was performed. Flow cytometry data was acquired on a FACSCanto II (BD Biosciences) using FACSDiva software (8.0.1) and the FCS files were analyzed using FlowJo 10.8.1 software (Beckton Dickinson and Company).
+ Open protocol
+ Expand
6

Flow Cytometric Analysis of EMT Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were collected, stained, and analyzed by flow cytometry (BD Cytoflex S flow cytometer) as follows. Staining for membrane surface molecules included use of the following antibodies: EpCAM-PE (phycoerythrin): [VU-1D9] (Abcam) and isotype control [MOPC-21] (BD Pharmingen); E-cadherin-PE: CD324 [DECMA-1] BioLegend) and isotype control [A95-1] (BD Pharmingen); and N-cadherin-APC (Allophycocyanin): CD325 [8C11] (BioLegend) and isotype control [27 (link)–35 (link)] (BD Pharmingen). Staining was performed following standard methods. Cells were stained for 30 min (EpCAM) and 20 min (E-cadherin and N-cadherin). For intracellular staining of CCT2 we used the antibody CCT2-PE: [NP_006422] (LSBio) and the isotype control [MOPC-21] (LSBio), following the method in ThermoFisher Scientific’s “Protocol A: two-step protocol: intracellular (cytoplasmic) proteins” and incubating the antibody for 70 min. When optimizing the CCT2 intracellular stain for CSS Autoprep conditions, we adjusted the antibody staining protocol for CCT2-PE to match the 20 min in the CSS Autoprep automated conditions. All data was generated using FCS Express 6 software (De Novo).
+ Open protocol
+ Expand
7

Cell Surface Antigen Analysis by FACS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell surface antigens were analysed by FACS on a BD FACSCalibur after 20 min staining at 4°C with antibodies to HLA class I–FITC (W6/32; BD), HLA-DR–FITC (L243; BD), IgG1–APC (MOPC-21; BD), IgG2a–FITC (G155-178; BD), IgG2a–Phycoerythrin (G155-178; BD), anti-CD46–APC (MEM-258; ImmunoTools, Friesoythe, Germany), anti-CD55–Phycoerythrin (IA10; BD) and anti-CD59–APC (OV9A2, eBioscience).
+ Open protocol
+ Expand
8

Detection of CD46, CD150, and Measles Virus H on Cell Surfaces

Check if the same lab product or an alternative is used in the 5 most similar protocols
For detection of CD46 and CD150 proteins on the surface of MT-1 and CCRF-CEM cells, antibodies specific for CD46 (clone E4.3) and CD150 (clone A12) directly conjugated to FITC and PE, respectively, as well as isotype controls (clones G155-178 and MOPC-21; all from BD Pharmingen) were used for staining for 1 hour. To determine expression of MV hemagglutinin (H) on the cell surface, cells were stained with a mouse monoclonal antibody specific for measles virus H (clone K29 (Liebert et al., 1990 (link))) or an IgG1 isotype control and subsequently stained with donkey antibodies specific for mouse IgG labeled with FITC (Abcam). Propidium Iodide Staining Solution (BD Pharmigen) was used to stain cells according to the manufacturer’s protocol. Annexin V coupled to FITC (BioLegend) was used to stain cells according to the manufacturer’s protocol. Cells were analyzed with a BD FACSCalibur flow cytometer.
+ Open protocol
+ Expand
9

Quantifying VLA-4 Expression and Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The VLA-4-specific ligand 4-((N’-2-methylphenyl)ureido)-phenylacetyl-L-leucyl-L-aspartyl-L-valyl-L-prolyl-L-alanyl-L-alanyl-L-lysine (LDV) and its FITC-conjugated analog (LDV-FITC probe) [30 (link),33 (link)] were synthesized at Commonwealth Biotechnologies. Mouse anti-human CD29/integrin β1 chain, clone MAR4 (PE), mouse anti-human CD49d/ integrin α4 chain, clone 9F10 (PE), and isotype control (mouse IgG1 κ, PE) clone MOPC-21 were purchased from BD Biosciences and used according to the instructions of the manufacturer. Human recombinant CXCL12/SDF-1α and recombinant human CXCL8/IL-8 were obtained from R&D Systems, Inc. All other reagents were from Sigma-Aldrich. Stock solutions were prepared in DMSO, at concentrations ~1000-fold higher than the final concentration. Usually, 1 μl of stock solution was added to 1 ml of cell suspension, yielding a final 0.1% DMSO concentration. Control samples were treated with an equal amount of pure DMSO (vehicle).
+ Open protocol
+ Expand
10

Quantifying HER2 and PD-L1 in Tumor Organoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine HER2 and PD-L1 surface expression, organoids were dissociated into single cells using TryplE supplemented with 1:1000 Rho kinase inhibitor. 25,000 single tumor cells were stained with Live/Dead® Fixable Aqua Dead Cell Stain Kit (Thermo Fisher Scientific, Cat. No. L34957) for 30 min on ice. Tumor cells were washed with PBS/EDTA buffer (PBS/2 mM EDTA/0.5% HSA) and stained with mouse anti-human HER2-APC (Neu24.7, BD Biosciences, Cat. No. 340554), anti-PD-L1-PE (29E.2A3, BD, Cat. No. 568079), or matched isotype controls IgG1-APC (MOPC21, BD Biosciences, Cat. No. 550854) and IgG2b,k-PE (27-35, BD, Cat. No. 555058) for 30 min at 4°C. All acquisitions were performed on a BD FACS Canto II. Data were analyzed with FlowJo v10.6.1 (TreeStar).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!